Vimarsana
Biggest News Aggregation in the World

Page 45 - Human Use News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Human Use. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Human Use Today - Breaking & Trending Today

Bristol-Myers's Abecma Receives CHMP Recommendation For Market Authorization - Vimarsana News

Bristol-Myers's Abecma Receives CHMP Recommendation For Market Authorization

(RTTNews) - Bristol-Myers Squibb Company (BMY) on Friday announced that the Committee for Medicinal Products for Human Use (CHMP) of the European ...

Europe Approves Neutropenia and Schizophrenia Treatments - Vimarsana News

Europe Approves Neutropenia and Schizophrenia Treatments

Recommendations were also endorsed to institute measures to reduce risks from cold and flu medicines containing pseudoephedrine.

Europe to withdraw PTC Therapeutics' rare muscle disorder drug - Vimarsana News

Europe to withdraw PTC Therapeutics' rare muscle disorder drug

PTC Therapeutics said on Thursday the European health regulator's advisory panel has issued a negative opinion for its drug to treat an inherited progressive muscle-wasting disorder, sending its...

PTC Therapeutics Shares Drop 13% After Negative Opinion From CHMP - Vimarsana News

PTC Therapeutics Shares Drop 13% After Negative Opinion From CHMP

By Stephen Nakrosis Shares of PTC Therapeutics were trading in the red after hours Thursday, following news the Committee for Medicinal Products for Human...

CHMP Issues Negative Opinion for Renewal of Conditional Marketing Authorization for Translarna™ (ataluren) Following Re-examination Procedure - Vimarsana News

CHMP Issues Negative Opinion for Renewal of Conditional Marketing Authorization for Translarna™ (ataluren) Following Re-examination Procedure

SOUTH PLAINFIELD, N.J., Jan. 25, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency issued a...